A Study of AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast Cancer

Condition:   Breast Cancer Intervention:   Drug: AC682 Sponsor:   Accutar Biotechnology Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials